Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Diagnosing TD in Clinical Practice

Leslie Citrome, MD, MPH, and Joseph P. McEvoy, MD, discuss diagnosis of tardive dyskinesia (TD) in clinical practice.
Leslie Citrome, MD, MPH
Joseph P. McEvoy, MD
Released: June 11, 2021

In this episode, Leslie Citrome, MD, MPH, and Joseph P. McEvoy, MD, discuss clinical assessment and diagnosis of tardive dyskinesia (TD). They review using the AIMS exam for identification of dyskinesia in patients in both the clinical setting and via telepsychiatry. They also review how often to perform the AIMS exam, how to assess the results, and why it is important.

Presenters:
Leslie Citrome, MD, MPH
Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Joseph P. McEvoy, MD
Professor
Psychiatry and Health Behavior
Psychiatrist
Augusta University
Augusta, Georgia

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant provided by
Neurocrine Biosciences

Related Content

Slides from a presentation that educates clinicians on how to formulate an approach to treat patients with bipolar disorder.

person default Thomas L. Schwartz, MD Released: July 23, 2021

Slides from a presentation that educates clinicians on how to formulate an approach to diagnose patients with bipolar disorder.

Manpreet K. Singh, MD, MS Released: July 22, 2021

Podcast from Clinical Care Options (CCO) with Drs John Kane and Rebecca Roma on the relationship of extrapyramidal symptoms (EPS), antiparkinsonian drugs, tardive dyskinesia (TD)

John M. Kane, MD Rebecca S. Roma, MD Released: July 20, 2021

Clinical Care Options (CCO) commentary by Jonathan M. Meyer, MD, on VMAT2 inhibitors in TD and anticholinergic exacerbation of TD symptoms.

Jonathan M. Meyer, MD Released: July 8, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue